IP Library › Assignment 027901/0269
Patent Assignment
Reel/Frame 027901/0269

Assignment of Assignor's Interest

Recorded: 2012-03-21 Pages: 41
Assignor
CYTRX CORPORATION
Executed: 2011-05-13
Assignee
ORPHAZYME APS
OLE MAALOS VEJ 3, COPENHAGEN, DK-2200, DENMARK
Covered Properties (10)
Hydroxylamine Derivatives Useful for Enhancing the Molecular Chaperon Production and the Preparation Thereof
Patent: 6,653,326 →
Application: 08/860,582 →
Optically Active Pyridyl-4H-1,2,4-Oxadiazine Derivative and Its Use in the Treatment of Vascular Diseases
Patent: 6,384,029 →
Application: 09/762,949 →
N-[2-Hydroxy-3-(1-Piperidinyl)Propoxy}Pyridine-1-Oxide-3-Carboximidoyl Chlorine and Its Use in the Treatment of Unsulin Resistance
Patent: 6,649,628 →
Application: 09/913,263 →
Pyridine-1-Oxide Derivative, and Process for Its Transformation into Pharmaceutically Effective Compounds
Patent: 7,126,002 →
Application: 10/257,755 →
Publication: US 2004/0006232
Method of Enhancing Cellular Production of Molecular Chaperon, Hydroxylamine Derivatives Useful for Enhancing the Chaperon Production and the Preparation Thereof
Patent: 7,148,239 →
Application: 10/618,157 →
Publication: US 2004/0019103
Method of Enhancing Cellular Production of Molecular Chaperone, Hydroxylamine Derivatives Useful for Enhancing the Chaperone Production and the Preparation Thereof
Patent: 7,745,465 →
Application: 10/618,162 →
Publication: US 2004/0067940
Pharmaceutically Effective Compounds
Patent: 7,361,655 →
Application: 10/889,966 →
Publication: US 2005/0043295
Pharmaceutically Effective Compounds
Patent: 7,550,457 →
Application: 11/981,422 →
Publication: US 2008/0058323
Pharmaceutically Effective Compounds
Application: 12/487,151 →
Publication: US 2009/0253690
Method of Enhancing Cellular Production of Molecular Chaperone, Hydroxylamine Derivatives Useful for Enhancing the Chaperone Production and the Preparation Thereof
Application: 12/823,823 →
Publication: US 2010/0267711
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 16, 2000
From: VIGH, LASZLO; NAGY, PETER LITERATI; SZILBEREKY, JENO; UROGDI, LASZLO
To: BIOREX RESEARCH & DEVELOPMENT CO.
Reel/Frame 010836/0148 →
Assignment of Assignor's Interest May 15, 2001
From: JEDNAKOVITS, ANDREA; UROGDI, LASZLO; DENES, LASZLO; KURUCZ, ISTVAN
To: BIOREX KUTATO ES FEJLESZTO RT.
Reel/Frame 011809/0110 →
Assignment of Assignor's Interest Dec 18, 2001
From: KURTHY, MARIA; BIRO, KATALIN; NAGY, KAROLY; UROGDI, LASZLO
To: BIOREX KUTATO ES FEJLESZTO RT.
Reel/Frame 012374/0696 →
Assignment of Assignor's Interest Jul 25, 2003
From: UROGDI, LASZLO; JEGESNE CSAKAI, ZITA; GRUBER, LAJOS; OTVOS, LASZLO
To: BIOREX KUTATO ES FEJLESZTO RT.
Reel/Frame 014317/0612 →
Assignment of Assignor's Interest Dec 8, 2004
From: CSAKAI, ZITA JEGESNE; MARVANYOS, EDE; UROGDI, LASZLO; TOROK, MAGDOLNA BATHONE
To: BIOREX RESEARCH AND DEVELOPMENT CO.
Reel/Frame 015435/0348 →
Assignment of Assignor's Interest Jul 15, 2005
From: BIROREX KUTATO ES FEJLESZTO RT.
To: CYTRX CORPORATION
Reel/Frame 016784/0135 →
Assignment of Assignor's Interest Aug 29, 2005
From: BIOREX KUTATÓ ÉS FEJLESZTÖ RT. ("V.A."); BRX RESEARCH AND DEVELOPMENT COMPANY LTD
To: CYTRX CORPORATION
Reel/Frame 016460/0725 →
Assignment of Assignor's Interest Dec 6, 2006
From: BRX MAGYARORSZAG RT
To: CYTRX CORPORATION
Reel/Frame 018590/0620 →
Assignment of Assignor's Interest Aug 4, 2009
From: BIOREX KUTATO ES FEJLESZTO RT. ("V.A."); BIOREX RESEARCH AND DEVELOPMENT CO.
To: CYTRX CORPORATION
Reel/Frame 023050/0893 →
Assignment of Assignor's Interest Aug 4, 2009
From: CSAKAI, ZITA JEGESNE; MARVANYOS, EDE; UROGDI, LASZLO; TOROK, MAGDOLNA BATHONE
To: BIOREX RESEARCH AND DEVELOPMENT CO.
Reel/Frame 023050/0725 →
Assignment of Assignor's Interest Aug 11, 2011
From: BIOREX KUTATO ES FEJLESZTO RT. ("V.A."); BRX RESEARCH AND DEVELOPMENT COMPANY LTD.
To: CYTRX CORPORATION
Reel/Frame 026733/0048 →
Assignment of Assignor's Interest Aug 11, 2011
From: VIGH, LASZLO; NAGY, PETER LITERATI; SZILBEREKY, JENO; UROGDI, LASZLO
To: BIOREX RESEARCH & DEVELOPMENT CO.
Reel/Frame 026733/0139 →
Change of Name Apr 11, 2018
From: ORPHAZYME APS
To: ORPHAZYME A/S
Reel/Frame 045911/0992 →
Security Interest Sep 6, 2019
From: ORPHAZYME A/S; ORPHAZYME US, INC.
To: KREOS CAPITAL VI (UK) LIMITED
Reel/Frame 050294/0026 →
Assignment of Assignor's Interest Jul 6, 2022
From: ORPHAZYME A/S
To: KEMPHARM, INC.
Reel/Frame 060592/0646 →
Assignment of Assignor's Interest Jul 6, 2022
From: KEMPHARM, INC.
To: KEMPHARM DENMARK A/S
Reel/Frame 060592/0595 →
Change of Name Oct 12, 2022
From: ORPHAZYME APS
To: ORPHAZYME A/S
Reel/Frame 061659/0984 →
Release of Security Interest Apr 4, 2024
From: KREOS CAPITAL VI (UK) LIMITED
To: ZEVRA DENMARK A/S (F/K/A KEMPHARM DENMARK A/S, SUCCESSOR IN INTEREST TO ORPHAZYME A/S)
Reel/Frame 067007/0706 →